Thomas Sands
Plastic Surgery · Metairie, LANPI 1225272149
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,494 of the $10,080 with a category attached, or 64.4%. AbbVie accounts for 72.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $2,963 and has fallen 60.0% since, to $1,186 in 2025.
Across 237 payments — averaging $42.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Revance Therapeutics, Inc.$769
- Merz North America, Inc.$440
- Integra Lifesciences Corporation$380
- Sientra, Inc.$262
- Motiva USA, LLC$223
- plus $742 from 17 others
What the payments were for
- Travel & lodging$1,89419%
- Food & beverage$6,49464%
- Education$170%
- Gifts$1,35013%
- Other$3263%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 173 | $7,264 |
| Revance Therapeutics, Inc. | 20 | $769 |
| Merz North America, Inc. | 6 | $440 |
| Integra Lifesciences Corporation | 3 | $380 |
| Sientra, Inc. | 1 | $262 |
| Motiva USA, LLC | 3 | $223 |
| Galderma Laboratories, L.p. | 6 | $215 |
| Vertex | 3 | $67 |
| Baxter Healthcare | 3 | $62 |
| Pacira Pharmaceuticals Incorporated | 3 | $61 |
| TELA Bio, Inc. | 3 | $46 |
| Davol Inc. | 1 | $43 |
| Trevena, Inc. | 2 | $42 |
| Heron Therapeutics, Inc. | 1 | $32 |
| Apyx Medical Corporation | 1 | $30 |
| Innovation Technologies Inc | 1 | $25 |
| Convatec Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Kerecis Limited | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,080 in reported general payments places this provider in the 85th percentile of 49 plastic surgery providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 13 | $192 |
| Celecoxib | 20 | $128 |
| Gabapentin | 24 | $65 |
| Ondansetron OdtOndansetron | 15 | $51 |
| Tramadol Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Metairie
- Daniel WomacMetairie$12K
- Hamid MassihaMetairie$3K
- Alireza SadeghiMetairie$3K
- John LindseyMetairie$2K
- Juan EscobarMetairie$1K
- Edward CampbellMetairie$13
- Abigail ChaffinNew Orleans$284K
- Jonathan WeilerBaton Rouge$62K
- Benjamin BoudreauxMandeville$42K
- Ruston SanchezBaton Rouge$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.